BMJ Open (Feb 2022)
Protocol for development of a core outcome set for clinical trials in melasma
- Jamie J Kirkham,
- Murad Alam,
- Jochen Schmitt,
- Sarah A Ibrahim,
- Bianca Y Kang,
- Daniel I Schlessinger,
- Sarah G Chiren,
- Jennifer C Tang,
- Emily Poon,
- Ian A Maher,
- Joseph F Sobanko,
- Todd V Cartee
Affiliations
- Jamie J Kirkham
- Centre for Biostatistics, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
- Murad Alam
- Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Jochen Schmitt
- Centre for Evidence-Based Healthcare, Medical Faculty Carl Gustav Carus,Technical University Dresden, Dresden, Germany
- Sarah A Ibrahim
- Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Bianca Y Kang
- Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Daniel I Schlessinger
- Division of Dermatology, Department of Internal Medicine, Washington University in St Louis, St Louis, Missouri, USA
- Sarah G Chiren
- Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Jennifer C Tang
- Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
- Emily Poon
- Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
- Ian A Maher
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA
- Joseph F Sobanko
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Todd V Cartee
- Department of Dermatology, Penn State Health, Hershey, Pennsylvania, USA
- DOI
- https://doi.org/10.1136/bmjopen-2020-046953
- Journal volume & issue
-
Vol. 12,
no. 2
Abstract
No abstracts available.